Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
NEW YORK, Jan. 18, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017http://www.reportlinker.com/p0761163/Infectious-Immunology-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Summary GlobalData's new report, "Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" provides key market data on the Infectious Immunology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within four market categories - Hepatitis Viruses, Retroviruses, Other Virology and Bacteriology. The report also provides company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older--a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Scope - Market size data for Infectious Immunology market categories - Hepatitis Viruses, Retroviruses, Other Virology and Bacteriology.- Annualized market revenues ($m) data for each of the segments and sub-segments within the four market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
- 2010 company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Infectious Immunology market in BRICS.
- Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthcare, bioMerieux S.A.,DiaSorin S.p.A, Qiagen N.V., Shanghai Kehua Bio-engineering Co., Ltd., Gen-Probe Incorporated, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc. and Becton, Dickinson and Company.
Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Infectious Immunology competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents1 Table of Contents 21.1 List of Tables 71.2 List of Figures 102 Introduction 122.1 What is This Report About? 123 Infectious Immunology in BRICS 133.1 Infectious Immunology, BRICS, Overall Revenue ($m), 2003-2017 133.2 Infectious Immunology, BRICS, Company share (2009-2010) 194 Infectious Immunology In Brazil 214.1 Infectious Immunology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 214.2 Hepatitis Viruses In Brazil 274.2.1 Hepatitis Viruses, Brazil, Overall Revenue (2003-2017) 274.3 Other Virology In Brazil 294.3.1 Other Virology, Brazil, Overall Revenue (2003-2017) 294.4 Retroviruses In Brazil 314.4.1 Retroviruses, Brazil, Overall Revenue (2003-2017) 314.5 Bacteriology In Brazil 334.5.1 Bacteriology, Brazil, Overall Revenue (2003-2017) 334.6 Infectious Immunology, Brazil, Distribution Share (2009-2010) 354.7 Infectious Immunology, Brazil, Company Share (2009-2010) 365 Infectious Immunology In Russian Federation 385.1 Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 385.2 Hepatitis Viruses In Russian Federation 445.2.1 Hepatitis Viruses, Russian Federation, Overall Revenue (2003-2017) 445.3 Retroviruses In Russian Federation 465.3.1 Retroviruses, Russian Federation, Overall Revenue (2003-2017) 465.4 Bacteriology In Russian Federation 485.4.1 Bacteriology, Russian Federation, Overall Revenue (2003-2017) 485.5 Other Virology In Russian Federation 505.5.1 Other Virology, Russian Federation, Overall Revenue (2003-2017) 505.6 Infectious Immunology, Russian Federation, Distribution Share (2009-2010) 525.7 Infectious Immunology, Russian Federation, Company Share (2009-2010) 536 Infectious Immunology In India 556.1 Infectious Immunology, India, Overall Revenue ($m), USD Actual, 2003-2017 556.2 Hepatitis Viruses In India 616.2.1 Hepatitis Viruses, India, Overall Revenue (2003-2017) 616.3 Retroviruses In India 636.3.1 Retroviruses, India, Overall Revenue (2003-2017) 636.4 Bacteriology In India 656.4.1 Bacteriology, India, Overall Revenue (2003-2017) 656.5 Other Virology in India 676.5.1 Other Virology, India, Overall Revenue (2003-2017) 676.6 Infectious Immunology, India, Distribution Share (2009-2010) 696.7 Infectious Immunology, India, Company Share (2009-2010) 707 Infectious Immunology In China 727.1 Infectious Immunology, China, Overall Revenue ($m), USD Actual, 2003-2017 727.2 Retroviruses In China 787.2.1 Retroviruses, China, Overall Revenue (2003-2017) 787.3 Hepatitis Viruses In China 807.3.1 Hepatitis Viruses, China, Overall Revenue (2003-2017) 807.4 Other Virology in China 827.4.1 Other Virology, China, Overall Revenue (2003-2017) 827.5 Bacteriology In China 847.5.1 Bacteriology, China, Overall Revenue (2003-2017) 847.6 Infectious Immunology, China, Distribution Share (2009-2010) 867.7 Infectious Immunology, China, Company Share (2009-2010) 878 Infectious Immunology In South Africa 898.1 Infectious Immunology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 898.2 Retroviruses In South Africa 958.2.1 Retroviruses, South Africa, Overall Revenue (2003-2017) 958.3 Hepatitis Viruses In South Africa 978.3.1 Hepatitis Viruses, South Africa, Overall Revenue (2003-2017) 978.4 Other Virology in South Africa 998.4.1 Other Virology, South Africa, Overall Revenue (2003-2017) 998.5 Bacteriology In South Africa 1018.5.1 Bacteriology, South Africa, Overall Revenue (2003-2017) 1018.6 Infectious Immunology, South Africa, Distribution Share (2009-2010) 1038.7 Infectious Immunology, South Africa, Company Share (2009-2010) 1049 Overview of Key Companies in BRICS Infectious Immunology Market 1069.1 Abbott Laboratories 1069.1.1 Company Overview 1069.1.2 Share in the BRICS Infectious Immunology Market 1079.2 F. Hoffmann-La Roche Ltd. 1089.2.1 Company Overview 1089.2.2 Share in the BRICS Infectious Immunology Market 1099.3 Siemens Healthcare 1109.3.1 Company Overview 1109.3.2 Share in the BRICS Infectious Immunology Market 1119.4 bioMerieux S.A. 1129.4.1 Company Overview 1129.4.2 Share in the BRICS Infectious Immunology Market 1139.5 DiaSorin S.p.A 1149.5.1 Company Overview 1149.5.2 Share in the BRICS Infectious Immunology Market 1159.6 Qiagen N.V. 1169.6.1 Company Overview 1169.6.2 Share in the BRICS Infectious Immunology Market 1179.7 Shanghai Kehua Bio-engineering Co., Ltd. 1189.7.1 Company Overview 1189.7.2 Share in the BRICS Infectious Immunology Market 1189.8 Gen-Probe Incorporated 1199.8.1 Company Overview 1199.8.2 Share in the BRICS Infectious Immunology Market 1209.9 Beckman Coulter, Inc. 1219.9.1 Company Overview 1219.9.2 Share in the BRICS Infectious Immunology Market 1229.10 Bio-Rad Laboratories, Inc. 1239.10.1 Company Overview 1239.10.2 Share in the BRICS Infectious Immunology Market 1249.11 Becton, Dickinson and Company 1259.11.1 Company Overview 1259.11.2 Share in the BRICS Infectious Immunology Market 1269.12 PerkinElmer, Inc. 1279.12.1 Company Overview 1279.13 Thermo Fisher Scientific Inc. 1279.13.1 Company Overview 1279.14 Transasia Bio-Medicals Ltd. 1279.14.1 Company Overview 1279.15 Span Diagnostics Ltd. 1289.15.1 Company Overview 1289.16 Trivitron Healthcare Pvt Ltd. 1289.16.1 Company Overview 1289.17 Cellestis Limited 1289.17.1 Company Overview 1289.18 Alere Inc. 1299.18.1 Company Overview 1299.19 Hologic, Inc. 1299.19.1 Company Overview 12910 Appendix 13010.1 Definitions of Markets Covered in the Report 13110.1.1 Infectious Immunology 13110.2 Research Methodology 13210.3 Secondary Research 13210.4 Primary Research 13310.5 Models 13310.6 Forecasts 13410.7 Expert Panels 13410.8 GlobalData Consulting 13410.9 Currency Conversion 13510.10 Contact Us 13510.11 Disclaimer 135
List of Tables
Table 1: Infectious Immunology, BRICS, Overall Revenue ($m), 2003-2017 14Table 2: Infectious Immunology, BRICS, Overall Revenue ($m), Historic, 2003-2010 16Table 3: Infectious Immunology, BRICS, Overall Revenue ($m), Forecast, 2010-2017 18Table 4: Infectious Immunology, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 20Table 5: Infectious Immunology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 22Table 6: Infectious Immunology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24Table 7: Infectious Immunology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26Table 8: Hepatitis Viruses, Brazil, Revenue ($m), Historic, 2003-2010 27Table 9: Hepatitis Viruses, Brazil, Revenue ($m), Forecast, 2010-2017 28Table 10: Other Virology, Brazil, Revenue ($m), Historic, 2003-2010 29Table 11: Other Virology, Brazil, Revenue ($m), Forecast, 2010-2017 30Table 12: Retroviruses, Brazil, Revenue ($m), Historic, 2003-2010 31Table 13: Retroviruses, Brazil, Revenue ($m), Forecast, 2010-2017 32Table 14: Bacteriology, Brazil, Revenue ($m), Historic, 2003-2010 33Table 15: Bacteriology, Brazil, Revenue ($m), Forecast, 2010-2017 34Table 16: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 35Table 17: Infectious Immunology, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 37Table 18: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 39Table 19: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 41Table 20: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 43Table 21: Hepatitis Viruses, Russian Federation, Revenue ($m), Historic, 2003-2010 44Table 22: Hepatitis Viruses, Russian Federation, Revenue ($m), Forecast, 2010-2017 45Table 23: Retroviruses, Russian Federation, Revenue ($m), Historic, 2003-2010 46Table 24: Retroviruses, Russian Federation, Revenue ($m), Forecast, 2010-2017 47Table 25: Bacteriology, Russian Federation, Revenue ($m), Historic, 2003-2010 48Table 26: Bacteriology, Russian Federation, Revenue ($m), Forecast, 2010-2017 49Table 27: Other Virology, Russian Federation, Revenue ($m), Historic, 2003-2010 50Table 28: Other Virology, Russian Federation, Revenue ($m), Forecast, 2010-2017 51Table 29: Infectious Immunology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 52Table 30: Infectious Immunology, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 54Table 31: Infectious Immunology, India, Overall Revenue ($m), USD Actual, 2003-2017 56Table 32: Infectious Immunology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 58Table 33: Infectious Immunology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 60Table 34: Hepatitis Viruses, India, Revenue ($m), Historic, 2003-2010 61Table 35: Hepatitis Viruses, India, Revenue ($m), Forecast, 2010-2017 62Table 36: Retroviruses, India, Revenue ($m), Historic, 2003-2010 63Table 37: Retroviruses, India, Revenue ($m), Forecast, 2010-2017 64Table 38: Bacteriology, India, Revenue ($m), Historic, 2003-2010 65Table 39: Bacteriology, India, Revenue ($m), Forecast, 2010-2017 66Table 40: Other Virology, India, Revenue ($m), Historic, 2003-2010 67Table 41: Other Virology, India, Revenue ($m), Forecast, 2010-2017 68Table 42: Infectious Immunology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 69Table 43: Infectious Immunology, India, Company share by Revenue ($m), USD Actual, 2009-2010 71Table 44: Infectious Immunology, China, Overall Revenue ($m), USD Actual, 2003-2017 73Table 45: Infectious Immunology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 75Table 46: Infectious Immunology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 77Table 47: Retroviruses, China, Revenue ($m), Historic, 2003-2010 78Table 48: Retroviruses, China, Revenue ($m), Forecast, 2010-2017 79Table 49: Hepatitis Viruses, China, Revenue ($m), Historic, 2003-2010 80Table 50: Hepatitis Viruses, China, Revenue ($m), Forecast, 2010-2017 81Table 51: Other Virology, China, Revenue ($m), Historic, 2003-2010 82Table 52: Other Virology, China, Revenue ($m), Forecast, 2010-2017 83Table 53: Bacteriology, China, Revenue ($m), Historic, 2003-2010 84Table 54: Bacteriology, China, Revenue ($m), Forecast, 2010-2017 85Table 55: Infectious Immunology, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 86Table 56: Infectious Immunology, China, Company share by Revenue ($m), USD Actual, 2009-2010 88Table 57: Infectious Immunology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 90Table 58: Infectious Immunology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 92Table 59: Infectious Immunology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 94Table 60: Retroviruses, South Africa, Revenue ($m), Historic, 2003-2010 95Table 61: Retroviruses, South Africa, Revenue ($m), Forecast, 2010-2017 96Table 62: Hepatitis Viruses, South Africa, Revenue ($m), Historic, 2003-2010 97Table 63: Hepatitis Viruses, South Africa, Revenue ($m), Forecast, 2010-2017 98Table 64: Other Virology, South Africa, Revenue ($m), Historic, 2003-2010 99Table 65: Other Virology, South Africa, Revenue ($m), Forecast, 2010-2017 100Table 66: Bacteriology, South Africa, Revenue ($m), Historic, 2003-2010 101Table 67: Bacteriology, South Africa, Revenue ($m), Forecast, 2010-2017 102Table 68: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 103Table 69: Infectious Immunology, South Africa, Company share by Revenue ($m), USD Actual, 2009-2010 105Table 70: Abbott Laboratories, Revenue ($m), BRICS Infectious Immunology Market, 2010 107Table 71: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2010 109Table 72: Siemens Healthcare, Revenue ($m), BRICS Infectious Immunology Market, 2010 111Table 73: bioMerieux S.A., Revenue ($m), BRICS Infectious Immunology Market, 2010 113Table 74: DiaSorin S.p.A, Revenue ($m), BRICS Infectious Immunology Market, 2010 115Table 75: Qiagen N.V., Revenue ($m), BRICS Infectious Immunology Market, 2010 117Table 76: Shanghai Kehua Bio-engineering Co., Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2010 118Table 77: Gen-Probe Incorporated, Revenue ($m), BRICS Infectious Immunology Market, 2010 120Table 78: Beckman Coulter, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2010 122Table 79: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2010 124Table 80: Becton, Dickinson and Company, Revenue ($m), BRICS Infectious Immunology Market, 2010 126Table 81: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 135
List of Figures
Figure 1: Infectious Immunology, BRICS, Overall Revenue ($m), 2003-2017 13Figure 2: Infectious Immunology, BRICS, Overall Revenue ($m), Historic, 2003-2010 15Figure 3: Infectious Immunology, BRICS, Overall Revenue ($m), Forecast, 2010-2017 17Figure 4: Infectious Immunology, BRICS, Company share (%), 2010 19Figure 5: Infectious Immunology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 21Figure 6: Infectious Immunology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 23Figure 7: Infectious Immunology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 25Figure 8: Hepatitis Viruses, Brazil, Revenue ($m), Historic, 2003-2010 27Figure 9: Hepatitis Viruses, Brazil, Revenue ($m), Forecast, 2010-2017 28Figure 10: Other Virology, Brazil, Revenue ($m), Historic, 2003-2010 29Figure 11: Other Virology, Brazil, Revenue ($m), Forecast, 2010-2017 30Figure 12: Retroviruses, Brazil, Revenue ($m), Historic, 2003-2010 31Figure 13: Retroviruses, Brazil, Revenue ($m), Forecast, 2010-2017 32Figure 14: Bacteriology, Brazil, Revenue ($m), Historic, 2003-2010 33Figure 15: Bacteriology, Brazil, Revenue ($m), Forecast, 2010-2017 34Figure 16: Infectious Immunology, Brazil, Company share (%), 2010 36Figure 17: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 38Figure 18: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 40Figure 19: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 42Figure 20: Hepatitis Viruses, Russian Federation, Revenue ($m), Historic, 2003-2010 44Figure 21: Hepatitis Viruses, Russian Federation, Revenue ($m), Forecast, 2010-2017 45Figure 22: Retroviruses, Russian Federation, Revenue ($m), Historic, 2003-2010 46Figure 23: Retroviruses, Russian Federation, Revenue ($m), Forecast, 2010-2017 47Figure 24: Bacteriology, Russian Federation, Revenue ($m), Historic, 2003-2010 48Figure 25: Bacteriology, Russian Federation, Revenue ($m), Forecast, 2010-2017 49Figure 26: Other Virology, Russian Federation, Revenue ($m), Historic, 2003-2010 50Figure 27: Other Virology, Russian Federation, Revenue ($m), Forecast, 2010-2017 51Figure 28: Infectious Immunology, Russian Federation, Company share (%), 2010 53Figure 29: Infectious Immunology, India, Overall Revenue ($m), USD Actual, 2003-2017 55Figure 30: Infectious Immunology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 57Figure 31: Infectious Immunology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 59Figure 32: Hepatitis Viruses, India, Revenue ($m), Historic, 2003-2010 61Figure 33: Hepatitis Viruses, India, Revenue ($m), Forecast, 2010-2017 62Figure 34: Retroviruses, India, Revenue ($m), Historic, 2003-2010 63Figure 35: Retroviruses, India, Revenue ($m), Forecast, 2010-2017 64Figure 36: Bacteriology, India, Revenue ($m), Historic, 2003-2010 65Figure 37: Bacteriology, India, Revenue ($m), Forecast, 2010-2017 66Figure 38: Other Virology, India, Revenue ($m), Historic, 2003-2010 67Figure 39: Other Virology, India, Revenue ($m), Forecast, 2010-2017 68Figure 40: Infectious Immunology, India, Company share (%), 2010 70Figure 41: Infectious Immunology, China, Overall Revenue ($m), USD Actual, 2003-2017 72Figure 42: Infectious Immunology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 74Figure 43: Infectious Immunology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 76Figure 44: Retroviruses, China, Revenue ($m), Historic, 2003-2010 78Figure 45: Retroviruses, China, Revenue ($m), Forecast, 2010-2017 79Figure 46: Hepatitis Viruses, China, Revenue ($m), Historic, 2003-2010 80Figure 47: Hepatitis Viruses, China, Revenue ($m), Forecast, 2010-2017 81Figure 48: Other Virology, China, Revenue ($m), Historic, 2003-2010 82Figure 49: Other Virology, China, Revenue ($m), Forecast, 2010-2017 83Figure 50: Bacteriology, China, Revenue ($m), Historic, 2003-2010 84Figure 51: Bacteriology, China, Revenue ($m), Forecast, 2010-2017 85Figure 52: Infectious Immunology, China, Company share (%), 2010 87Figure 53: Infectious Immunology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 89Figure 54: Infectious Immunology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 91Figure 55: Infectious Immunology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 93Figure 56: Retroviruses, South Africa, Revenue ($m), Historic, 2003-2010 95Figure 57: Retroviruses, South Africa, Revenue ($m), Forecast, 2010-2017 96Figure 58: Hepatitis Viruses, South Africa, Revenue ($m), Historic, 2003-2010 97Figure 59: Hepatitis Viruses, South Africa, Revenue ($m), Forecast, 2010-2017 98Figure 60: Other Virology, South Africa, Revenue ($m), Historic, 2003-2010 99Figure 61: Other Virology, South Africa, Revenue ($m), Forecast, 2010-2017 100Figure 62: Bacteriology, South Africa, Revenue ($m), Historic, 2003-2010 101Figure 63: Bacteriology, South Africa, Revenue ($m), Forecast, 2010-2017 102Figure 64: Infectious Immunology, South Africa, Company share (%), 2010 104Figure 65: Abbott Laboratories, Company Share (%), BRICS Infectious Immunology Market, 2010 107Figure 66: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Infectious Immunology Market, 2010 109Figure 67: Siemens Healthcare, Company Share (%), BRICS Infectious Immunology Market, 2010 111Figure 68: bioMerieux S.A., Company Share (%), BRICS Infectious Immunology Market, 2010 113Figure 69: DiaSorin S.p.A, Company Share (%), BRICS Infectious Immunology Market, 2010 115Figure 70: Qiagen N.V., Company Share (%), BRICS Infectious Immunology Market, 2010 117Figure 71: Gen-Probe Incorporated, Company Share (%), BRICS Infectious Immunology Market, 2010 120Figure 72: Beckman Coulter, Inc., Company Share (%), BRICS Infectious Immunology Market, 2010 122Figure 73: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Infectious Immunology Market, 2010 124Figure 74: Becton, Dickinson and Company, Company Share (%), BRICS Infectious Immunology Market, 2010 126
Companies mentioned
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
bioMerieux S.A.
DiaSorin S.p.A
Qiagen N.V.
Shanghai Kehua Bio-engineering Co., Ltd.
Gen-Probe Incorporated
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
PerkinElmer, Inc.
Thermo Fisher Scientific Inc.
Transasia Bio-Medicals Ltd.
Span Diagnostics Ltd.
Trivitron Healthcare Pvt Ltd.
Cellestis Limited
Alere Inc.
Hologic, Inc.
To order this report: General Medicine and Specialty Medicine Industry: Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker